Twist Bioscience Corp (TWST)
43.80
-0.87
(-1.95%)
USD |
NASDAQ |
May 07, 15:26
Twist Bioscience Cash from Financing (Quarterly): 1.828M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.828M |
December 31, 2023 | -1.473M |
September 30, 2023 | 0.442M |
June 30, 2023 | -0.661M |
March 31, 2023 | 1.525M |
December 31, 2022 | -0.395M |
September 30, 2022 | 1.24M |
June 30, 2022 | -1.311M |
March 31, 2022 | 271.62M |
December 31, 2021 | -1.011M |
September 30, 2021 | 1.575M |
June 30, 2021 | -0.765M |
March 31, 2021 | 1.451M |
Date | Value |
---|---|
December 31, 2020 | 326.92M |
September 30, 2020 | 5.574M |
June 30, 2020 | 108.06M |
March 31, 2020 | 188.04M |
December 31, 2019 | 2.057M |
September 30, 2019 | 2.928M |
June 30, 2019 | 84.28M |
March 31, 2019 | -1.634M |
December 31, 2018 | 73.00M |
September 30, 2018 | 6.583M |
June 30, 2018 | 24.83M |
March 31, 2018 | 54.75M |
December 31, 2017 | 2.662M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.473M
Minimum
Dec 2023
326.92M
Maximum
Dec 2020
49.60M
Average
1.55M
Median
Cash from Financing (Quarterly) Benchmarks
Tandem Diabetes Care Inc | 13.59M |
Perspective Therapeutics Inc | 0.352M |
Xtant Medical Holdings Inc | 0.325M |
Asensus Surgical Inc | 0.172M |
Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -19.42M |
Cash from Investing (Quarterly) | -5.24M |
Free Cash Flow | -95.52M |
Free Cash Flow Per Share (Quarterly) | -0.3466 |
Free Cash Flow to Equity (Quarterly) | -20.03M |
Free Cash Flow to Firm (Quarterly) | -20.03M |
Free Cash Flow Yield | -3.80% |